GTCR proposes divestiture to US FTC in Surmodics case
GTCR LLC proposed selling off part of subsidiary Biocoat’s business to a third party as a divestiture in its deal to acquire Surmodics, the company told a US District Court judge....To view the full article, register now.
Already a subscriber? Click here to view full article